An Open Label Extension of a Study of Topiramate in Chronic Migraine.
Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the long-term safety and effectiveness of topiramate
for the prevention of headaches in adults with chronic migraine. Topiramate has been approved
to prevent migraine headaches.
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.